Hospital Delivery Charges Significantly Higher When Babies Conceived Through Assisted Reproductive Technologies
By Miriam Zoll,
Reporting on Health
| 03. 04. 2014
A new study published in the Journal of Perinatology [1] online has found that from 2009-2011 in California, hospital delivery charges associated with babies born through assisted reproductive technologies (ART) or artificial insemination (AI) were significantly higher than charges for babies born through natural conception –– in some cases exceeding $1.2 million per infant.
The retrospective study was based on 2009-2011 data from the California Office of Statewide Health Planning and Development and conducted by researchers from the Loma Linda University School of Medicine.
In 2011, statewide average hospital charges for maternity care for women who delivered ART/AI infants were almost fifty percent higher than fees for non-ART infants born late preterm or at term––$35,768 compared to $18,654. The higher charges are linked to a 24- to 27-fold increase across California of multiple births, and significantly higher rates of preterm births, lower birth weights, fetal anomalies and stillbirth, among infants born through ART/AI. In 2009, there were 5,710 ART/AI live births in California and 1,718 of these births -- or 30.1 percent –– were multiple births consisting of twins, triplets...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
